MYLAN 6727 MYLAN 6727 (Zonisamide 100 mg)
Pill imprint MYLAN 6727 MYLAN 6727 has been identified as Zonisamide 100 mg.
Zonisamide is used in the treatment of migraine prevention; seizures; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 6727 MYLAN 6727 (Zonisamide 100 mg)
- 100 mg
- Purple / Blue
- 18.00 mm
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
sodium lauryl sulfate
FD&C Red No. 3
|NDC Code||Manufacturer / Repackager|
|51079-0768||UDL Laboratories Inc|
|16590-0539||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about zonisamide
- Other brands: Zonegran
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...